---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011501"
form_type: "8-K"
ticker: "BEAM"
cik: "0001745999"
company_name: "Beam Therapeutics Inc."
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:50:10.779642+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Beam Therapeutics shareholders elect three Class II directors, ratify auditor, approve say-on-pay

## Summary
- All three director nominees (Fishman, Ho, Walsh) elected with ~39.5M votes each.
- Deloitte & Touche ratified as auditor for FY2022 with 51.8M for, 3.1M against.
- Advisory vote on executive compensation approved with 36.9M for, 5.7M against.
- Shareholders selected every year as the frequency of say-on-pay votes; board adopts annual policy.

## SEC filing metadata
- accession: 0000950170-22-011501
- form_type: 8-K
- ticker: BEAM
- cik: 0001745999
- company_name: Beam Therapeutics Inc.
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1745999/000095017022011501/0000950170-22-011501-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1745999/000095017022011501/beam-20220608.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011501
- JSON: https://secwatch.observer/filing/0000950170-22-011501.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011501.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.